Predictive Factors for the Development of Gallbladder Necrosis.

c-reactive protein cholecsystitis cholecystectomy gallbladder necrosis predictive factors smoking status white cell count

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Aug 2024
Historique:
accepted: 31 08 2024
medline: 1 10 2024
pubmed: 1 10 2024
entrez: 1 10 2024
Statut: epublish

Résumé

Introduction Acute cholecystitis is a common complication of gallstone disease. Likewise, gallbladder necrosis is a complication of cholecystitis associated with higher risks of morbidity and mortality. Identification of risk factors which portend to gallbladder necrosis is key in prioritizing the management of higher-risk patients. This study aimed to identify such factors that predict the development of gallbladder necrosis. Method A retrospective review of all patients undergoing emergency cholecystectomy in a tertiary hospital over a two-year period was performed. Gallbladder necrosis was diagnosed on histopathological examination of operative specimens. Multivariable logistic regression was performed to determine risk factors for gallbladder necrosis. Results A total of 163 patients underwent acute cholecystectomy and 43 (26%) had proven gallbladder necrosis. Multivariable analysis demonstrated that elevated white cell count (WCC) (OR 1.122, 95%CI 1.031-1.221, p=0.007), elevated C-reactive protein (CRP) (OR 1.004, 95%CI 1.001-1.008, p=0.022) and positive smoking status (OR 5.724, 95%CI 1.323-24.754, p=0.020) were independently predictive of gallbladder necrosis. Notably, advancing age, elevated BMI, diabetes mellitus or American Society of Anesthesiologists (ASA) grade were not found to be associated with developing necrosis. Conclusion Patients at risk of gallbladder necrosis include those with higher WCC, CRP, and active smokers. Given the increased potential complications, these risk factors should be identified early in the management of those admitted with gallstone disease to ensure such patients receive aggressive medical therapy alongside timely and guided surgical intervention.

Identifiants

pubmed: 39350859
doi: 10.7759/cureus.68310
pmc: PMC11441457
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e68310

Informations de copyright

Copyright © 2024, Maharajh et al.

Déclaration de conflit d'intérêts

Human subjects: Consent was obtained or waived by all participants in this study. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Auteurs

Sandeep Maharajh (S)

Northern Oesophago-Gastric Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, GBR.

Joshua Brown (J)

Northern Oesophago-Gastric Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, GBR.

Jakub Chmelo (J)

Northern Oesophago-Gastric Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, GBR.

Pooja Prasad (P)

Northern Oesophago-Gastric Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, GBR.

Alexander W Phillips (AW)

Northern Oesophago-Gastric Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, GBR.

Classifications MeSH